302 related articles for article (PubMed ID: 7763233)
1. Generation of the precursor (lyso-PAF) of platelet-activating factor via a CoA-dependent transacylase.
Blank ML; Fitzgerald V; Smith ZL; Snyder F
Biochem Biophys Res Commun; 1995 May; 210(3):1052-8. PubMed ID: 7763233
[TBL] [Abstract][Full Text] [Related]
2. The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity.
Blank ML; Smith ZL; Fitzgerald V; Snyder F
Biochim Biophys Acta; 1995 Feb; 1254(3):295-301. PubMed ID: 7857969
[TBL] [Abstract][Full Text] [Related]
3. A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway.
Uemura Y; Lee TC; Snyder F
J Biol Chem; 1991 May; 266(13):8268-72. PubMed ID: 2022643
[TBL] [Abstract][Full Text] [Related]
4. [Studies on acetyl-CoA:lyso platelet activating factor acetyltransferase of rat spleen microsomes--solubilization and substrate specificity].
Seyama K
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):766-75. PubMed ID: 3781469
[TBL] [Abstract][Full Text] [Related]
5. Conversion of 1-O-[3H]alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils.
Venable ME; Nieto ML; Schmitt JD; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18691-8. PubMed ID: 1917993
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of platelet-activating factor in cultured mast cells. Involvement of the CoA-independent transacylase demonstrated by analysis of the molecular species of platelet-activating factor.
Colard O; Bidault J; Breton M; Ninio E
Eur J Biochem; 1993 Sep; 216(3):835-40. PubMed ID: 8404903
[TBL] [Abstract][Full Text] [Related]
8. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
10. Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide.
Svetlov SI; Liu H; Chao W; Olson MS
Biochim Biophys Acta; 1997 Jun; 1346(2):120-30. PubMed ID: 9219895
[TBL] [Abstract][Full Text] [Related]
11. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
[TBL] [Abstract][Full Text] [Related]
13. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation.
Venable ME; Olson SC; Nieto ML; Wykle RL
J Biol Chem; 1993 Apr; 268(11):7965-75. PubMed ID: 8463317
[TBL] [Abstract][Full Text] [Related]
15. Non-enzymatic platelet-activating factor formation by acetylated proteins.
Thanou PG; Tsoukatos DC
FEBS Lett; 2004 Aug; 573(1-3):11-4. PubMed ID: 15327967
[TBL] [Abstract][Full Text] [Related]
16. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor biosynthesis and degradation in rat glomeruli.
Zanglis A; Lianos EA
J Lab Clin Med; 1987 Sep; 110(3):330-7. PubMed ID: 3611955
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of platelet activating factor (PAF) and related ether lipids by neonatal rat myocytes.
Qian CG; Lee TC; Snyder F
J Lipid Mediat; 1989; 1(2):113-23. PubMed ID: 2519887
[TBL] [Abstract][Full Text] [Related]
19. CD2 triggering stimulates the formation of platelet-activating factor-acether from alkyl-arachidonoyl-glycerophosphocholine in a human CD4+ T lymphocyte clone.
Le Gouvello S; Vivier E; Debre P; Thomas Y; Colard O
J Immunol; 1992 Aug; 149(4):1289-93. PubMed ID: 1354232
[TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells.
Botitsi E; Mavri-Vavayanni M; Siafaka-Kapadai A
J Lipid Res; 1998 Jun; 39(6):1295-304. PubMed ID: 9643362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
